Innogene
이노진 · 344860
Materials Chemicals · KOSDAQ
Market cap US$11.5M (₩15.8B)
Overview
Innogene makes cosmeceutical products, a category blending cosmetics with pharmaceutical-grade ingredients, focused on hair-loss relief and problem-skin care, including scalp treatments, home-care kits, scalp-care devices, health supplements, and pharmaceuticals.
It supplies clinics and hospitals across South Korea and exports to markets including the United States, China, Singapore, Hong Kong, and Malaysia. Listed on KOSDAQ, South Korea's tech and small-cap board, the company earns the large majority of its revenue from its hair-loss product line, with skin-beauty products making up the remainder.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$7.3M
- FY2024US$6.5M
- FY2025US$6M
Operating profit
- FY2023US$888.7K
- FY2024US$456.9K
- FY2025US$3.3K
Net income
- FY2023US$1M
- FY2024US$684.9K
- FY2025US$208.6K
Key ratios (FY2025)
Price charts coming soon
Interactive price history isn't here yet. Would you use it?